newsfilter
← Latest News
PR Newswire·

POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions

  • POMDOCTOR LIMITED (NASDAQ: POM) highlighted the strategic importance of its real-world data ("RWD") assets for transforming healthcare delivery & decision-making on November 11, 2026.
  • The Company aims to leverage RWD from clinical practice, wearable devices, medication records & daily activities to bridge gaps between research & practice for evidence-based medical decisions.
  • RWD applications are expanding across pharmaceutical research to complement trials, clinical practice to support physician guidelines, & payment systems to evaluate cost-effectiveness & risk management.
  • Pomdoctor is building an integrated RWD ecosystem that combines physiological indicators, behavioral patterns, remote patient monitoring data & payment information with AI analytics.
  • The Company plans to establish a continuous data feedback loop connecting health monitoring, risk assessment & personalized interventions to shift care from reactive to predictive models.
  • Chairman & CEO Zhenyang Shi stated the Company is integrating AI & wearable technologies to transform fragmented data into actionable insights for personalized healthcare.
  • Pomdoctor's business model includes an internet hospital platform & pharmaceutical supply chain, currently focusing on AI-enabled solutions & a four-tier revenue structure spanning B2C subscriptions, B2B services & RWS/RWD services.
  • Forward-looking statements indicate plans to strengthen revenue streams, commercialize RWD applications, & explore international markets while acknowledging risks related to regulation, data security & AI deployment.
Company
POMDOCTOR LIMITED
Keywords
POMDOCTOR LIMITED